Search Results - "Permuth, J."

Upregulation of miRNA-155 promotes tumour angiogenesis by targeting VHL and is associated with poor prognosis and triple-negative breast cancer by Kong, W, He, L, Richards, E J, Challa, S, Xu, C-X, Permuth-Wey, J, Lancaster, J M, Coppola, D, Sellers, T A, Djeu, J Y, Cheng, J Q

“…MicroRNA-155 (miR-155) is frequently upregulated in various types of human cancer; however, its role in cancer angiogenesis remains unknown. Here, we…”
Get full text

Neoadjuvant Chemotherapy For Patients With Intrahepatic Cholangiocarcinoma: A Propensity-Score Matched Survival Analysis by Utama, O., Permuth, J., Dagne, G., Sanchez-Anguiano, A., Allman, A., Denbo, J., Kim, R., Anaya, D.

Get full text

The precede consortium: A longitudinal international cohort study of individuals with a high-risk of pancreatic cancer by García García de Paredes, A., Katona, B., Zogopoulos, G., Brand, R., Kaul, V., Earl, J., Tempero, M., Kupfer, S., Paiella, S., Farrell, J., Sears, R., Sheppard, B., Grossberg, A., Idos, G., Chung, D., Golan, T., Friedman, E., Laish, I., Kwon, R., Stoffel, E., Merchant, N., Sussman, D., Brentnall, T., Gaddam, S., Jeter, J., Klute, K., Lowy, A., Liau, J., Lindberg, J., Permuth, J., Kastrinos, F., Bi, Y., Carpizo, D., Lin, J., Schrader, I., Lucas, A., Wadlow, R., Greenhalf, W., Shan, Y., Simeone, D.

Get full text

BRCA1 and BRCA2 mutations account for a large proportion of ovarian carcinoma cases by Pal, Tuya, Permuth‐Wey, Jenny, Betts, Judith A., Krischer, Jeffrey P., Fiorica, James, Arango, Hector, LaPolla, James, Hoffman, Mitchell, Martino, Martin A., Wakeley, Katie, Wilbanks, George, Nicosia, Santo, Cantor, Alan, Sutphen, Rebecca

“…BACKGROUND It is believed that BRCA1 and BRCA2 germline mutations account for the majority of hereditary ovarian carcinomas; however, to the authors'…”
Get full text

Rare Germline Variants in ATM Predispose to Prostate Cancer: A PRACTICAL Consortium Study by Karlsson, Questa, Brook, Mark N., Dadaev, Tokhir, Wakerell, Sarah, Saunders, Edward J., Muir, Kenneth, Neal, David E., Giles, Graham G., MacInnis, Robert J., Thibodeau, Stephen N., McDonnell, Shannon K., Cannon-Albright, Lisa, Teixeira, Manuel R., Paulo, Paula, Cardoso, Marta, Huff, Chad, Li, Donghui, Yao, Yu, Scheet, Paul, Permuth, Jennifer B., Stanford, Janet L., Dai, James Y., Ostrander, Elaine A., Cussenot, Olivier, Cancel-Tassin, Géraldine, Hoegel, Josef, Herkommer, Kathleen, Schleutker, Johanna, Tammela, Teuvo L.J., Rathinakannan, Venkat, Sipeky, Csilla, Wiklund, Fredrik, Grönberg, Henrik, Aly, Markus, Isaacs, William B., Dickinson, Jo L., FitzGerald, Liesel M., Chua, Melvin L.K., Nguyen-Dumont, Tu, Schaid, Daniel J., Southey, Melissa C., Eeles, Rosalind A., Kote-Jarai, Zsofia

“…Germline ATM mutations are suggested to contribute to predisposition to prostate cancer (PrCa). Previous studies have had inadequate power to estimate variant…”
Get full text

BRCA1 and BRCA2 Mutations in a Study of African American Breast Cancer Patients by PAL, Tuya, PERMUTH-WEY, Jenny, HOLTJE, Tricia, SUTPHEN, Rebecca

“…The spectrum of mutations in BRCA1 and BRCA2 among African Americans has not been well characterized because most studies to date have been done in Caucasian…”
Get full text